Speaker illustration

Associate Professor William Jones

Duke University Medical Center, Durham (United States of America)

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

Date: 2 December 2013

Journal: European Heart Journal

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb